Identification of men with the highest risk of early disease recurrence after radical prostatectomy

被引:19
|
作者
Sundi, Debasish [1 ]
Wang, Vinson [1 ]
Pierorazio, Phillip M. [1 ]
Han, Misop [1 ]
Partin, Alan W. [1 ]
Tran, Phuoc T. [1 ]
Ross, Ashley E. [1 ]
Bivalacqua, Trinity J. [1 ]
机构
[1] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA
来源
PROSTATE | 2014年 / 74卷 / 06期
关键词
intraoperative therapy; early biochemical recurrence; prostate cancer; multimodal therapy; RANDOMIZED CLINICAL-TRIAL; LYMPH-NODE DISSECTION; ADJUVANT RADIOTHERAPY; INTRAOPERATIVE RADIOTHERAPY; POSTOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; CANCER; METASTASES;
D O I
10.1002/pros.22780
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Men destined to have early biochemical recurrence (BCR) following radical prostatectomy (RP) may be optimal candidates for multimodal treatment. Here we identified pre-operative predictors of early BCR within a surgical cohort who recurred. METHODS An institutional prostate cancer (PCa) database containing over 20,000 patients was queried to identify 1,471 men who had BCR after RP, and pre-operative predictors of early versus late BCR were assessed. Early BCR was defined as recurrence within 1 year after RP. Within the recurrence cohort, those with National Comprehensive Cancer Network (NCCN) high-risk features were more likely to experience early BCR. Therefore, in all NCCN high-risk men in the database, we abstracted detailed pathologic biopsy data. Among 753 high-risk men, 41 alternate multivariable criteria were assessed for their ability to predict early BCR in crude and adjusted logistic regression models. RESULTS The criteria that best identified those likely to experience early BCR are primary Gleason pattern 5 on biopsy or >= 4 cores containing pattern 4 (odds ratio 3.17, P < 0.001). These criteria included 26.7% of NCCN high-risk men. Additionally, these criteria selected for men within the high-risk classification who were at significantly higher risk of subsequent metastasis (adjusted hazard ratio 3.04, P < 0.001) and cancer-specific death (adjusted hazard ratio 3.27, P < 0.001). CONCLUSIONS In men with PCa who present with high-risk features, pre-operative criteria have the ability to discriminate the subgroup most likely to experience early BCR after RP. Men at risk for early disease recurrence may be the most suitable candidates for multimodal therapy. Prostate 74:628-636, 2014. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:628 / 636
页数:9
相关论文
共 50 条
  • [31] The risk of biochemical recurrence for intermediate-risk prostate cancer after radical prostatectomy
    Kurbegovic, Sorel
    Berg, Kasper Drimer
    Thomsen, Frederik Birkebaek
    Gruschy, Lisa
    Iversen, Peter
    Brasso, Klaus
    Roder, Martin Andreas
    SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 (06) : 450 - 456
  • [32] Treatment outcome by risk group after radical prostatectomy in Japanese men
    Egawa, S
    Suyama, K
    Arai, Y
    Tsukayama, C
    Matsumoto, K
    Kuwao, S
    Baba, S
    INTERNATIONAL JOURNAL OF UROLOGY, 2001, 8 (06) : 295 - 300
  • [33] Statin Use after Radical Prostatectomy Reduces Biochemical Recurrence in Men With Prostate Cancer
    Song, Cheryn
    Park, Sejun
    Park, Jinsung
    Shim, Myungsun
    Kim, Aram
    Jeong, In Gab
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    PROSTATE, 2015, 75 (02): : 211 - 217
  • [34] The body mass index is not a negative predictor for recurrence after radical prostatectomy in European men
    Pfitzenmaier, Jesco
    Pritsch, Maria
    Fritsch, Frederik
    Haferkamp, Axel
    Gilfrich, Christian
    Buse, Stephan
    Djakovic, Nenad
    Jakobi, Hildegard
    Hohenfellner, Markus
    JOURNAL OF UROLOGY, 2008, 179 (04): : 66 - 66
  • [35] A Machine Learning Approach to Predict an Early Biochemical Recurrence after a Radical Prostatectomy
    Park, Seongkeun
    Byun, Jieun
    Woo, Ji Young
    APPLIED SCIENCES-BASEL, 2020, 10 (11):
  • [36] Risk of biochemical recurrence after radical prostatectomy among men using 5α-reductase inhibitors and alpha-blockers
    Murtola, T. J.
    Tammela, T. L. J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E349 - E349
  • [37] Biochemical Recurrence After Radical Prostatectomy With or Without Pelvic Lymphadenectomy in Korean Men With High-risk Prostate Cancer
    Ku, Ja Hyeon
    Jeong, Chang Wook
    Park, Yong Hyun
    Cho, Min Chul
    Kwak, Cheol
    Kim, Hyeon Hoe
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (05) : 656 - 662
  • [38] Preoperative parameters for predicting early prostate cancer recurrence after radical prostatectomy
    Nelson, CP
    Rubin, MA
    Strawderman, M
    Montie, JE
    Sanda, MG
    UROLOGY, 2002, 59 (05) : 740 - 745
  • [39] PRE-OPERATIVE PREDICTORS OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
    Sundi, Debasish
    Pierorazio, Phillip
    Ross, Ashley
    Humphreys, Elizabeth
    Han, Misop
    Partin, Alan
    Bivalacqua, Trinity
    JOURNAL OF UROLOGY, 2013, 189 (04): : E553 - E554
  • [40] ARE EAU RISK GROUPS RELIABLE IN THE STRATIFICATION OF MEN WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY AND RESTAGED WITH PSMA-PET?
    Gandaglia, Giorgio
    Necchi, Andrea
    Raggi, Daniele
    Stabile, Armando
    Cucchiara, Vito
    Mazzone, Elio
    Sorce, Gabriele
    Pellegrino, Francesco
    Scuderi, Simone
    Barletta, Francesco
    Robesti, Daniele
    Pellegrino, Antony
    Quarta, Leonardo
    Zaurito, Paolo
    Zaffuto, Emanuele
    Picchio, Maria
    Gajate, Ana Maria Samanes
    Gianolli, Luigi
    Marra, Giancarlo
    Gontero, Paolo
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2023, 209 : E550 - E550